MD, PHD
DEPARTMENT OF TRANSLATIONAL RESEARCH AND NEW TECHNOLOGIES IN MEDICINE AND SURGERY, UNIVERSITY OF PISA. UNIT OF MEDICAL ONCOLOGY 2, AZIENDA OSPEDALIERA-UNIVERSITARIA PISANA, PISA, ITALY
About Our Speaker
3L therapies options and prognostic factors in the treatment of mCRC patients.